National Resilience

National Resilience, Inc. (often referred to simply as Resilience) is an American biotechnology and biomanufacturing company based in San Diego, California. It is particularly notable in the COVID-19 pandemic because of its role in manufacturing the mRNA used in Moderna's mRNA vaccines.

Resilience was founded in November 2020 by Robert Nelsen of ARCH Venture Partners.¹⁾

The mRNA used in Moderna's mRNA vaccines is manufactured by National Resilience, a company that was founded in November 2020, with CIA ties.²⁾

Reinventing biomanufacturing’

National Resilience was founded relatively recently, in November 2020, and describes itself as “a manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption.”

It has since been building “a sustainable network of high-tech, end-to-end manufacturing solutions with the aim to ensure the medicines of today and tomorrow can be made quickly, safely and at scale.”

It further plans to “reinvent biomanufacturing” and “democratize access to medicines,” namely gene therapies, experimental vaccines and other “medicines of tomorrow.” ³⁾

Preparing for tomorrow, today. We believe the future can’t wait. That’s why we’re building Resilience to be here when you need us, ready to make important new medicines or respond to a global health crisis. We are the next generation of life science manufacturing. Resilience was born to address two defining challenges. 1. Manufacturing supply chains are needed that can withstand disruptive shocks and safeguard health security. 2. Biopharmaceutical manufacturing has not kept pace with scientific advancement, preventing new discoveries from reaching patients at speed or scale.

Resilience is creating a first-of-its-kind ecosystem for advanced biopharmaceutical manufacturing. We provide a network of high-tech, end-to-end manufacturing and development solutions to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale.

We continuously invest in R&D for next generation manufacturing and development, freeing our partners to focus on the discoveries that impact lives. Resilience offers customized and scalable processes, the highest quality and regulatory capabilities, and world-class talent and facilities for complex and novel medicines. This includes cell and gene therapies, viral vectors, vaccines, proteins, and new discoveries.

Through manufacturing that’s faster, safer, and more flexible, we safeguard the quality of important medicines and protect the resilience of a vital supply chain. ⁴⁾

Resilience offers a broad mix of customized manufacturing and development capabilities to serve the needs of biopharmaceutical companies at all stages of the drug development process – from pre-clinical development to commercial supply. ⁵⁾

Board of Directors is who's who list of kingpins from intelligence to big pharma full text list needed but sample pic.

⁶⁾

Robert Nelsen Chairman, Resilience Founder ARCH

Patrick Y. Yang, PhD Vice Chairman, Former EVP Juno, Roche, Genentech

Rahul Singhvi, ScD Co-founder, CEO

Frances Arnold, PhD Nobel Prize Laureate, CalTech Professor

George Barrett Former Chairman & CEO, Cardinal Health

Mitchell E. Daniels, Jr. President, Purdue University, Former Governor of Indiana

Chris Darby CEO, In-Q-Tel

Susan Desmond-Hellmann, MD, MPH Former CEO, Bill & Melinda Gates Foundation Current Senior Advisor and Pfizer Board member

Kaye Foster HR Executive

Scott Gottlieb M.D. Partner, NEA, Former Commissioner, FDA ( note - Scott Gottlieb was elected as an independent member of the board of directors of Pfizer, Inc. in June 2019. Scott joined the Illumina, Inc. board of directors in February 2020 and the National Resilience, Inc. board of directors in November 2020.)

Joseph Robert Kerrey - Allen & Co, Former United States Senator (Kerrey led official 9-11 Report Committee that never mentions WTC7 or other anomalies a whitewash at its best) ⁷⁾

Drew Oetting Co-founder & President, 8VC Co-founder Affinity

Denice Torres CEO, Ignited Group, Former CEO, Johnson & Johnson; McNeil

Rahul Singhvi, SC.D. Co-founder, CEO

Sandy Mahatme, LLM President, COO & CFO

Patrick Y. Yang, PhD Vice Chairman

Viet Nguyen Chief Manufacturing Officer

Syed T. Husain Chief Commercial Officer

Georgeta Puscalau Chief Quality Officer

Rich Stoner, PhD Chief Scientific Officer

Elliot Menschik, MD, PhD Chief Digital Officer

Ori Solomon Chief Legal Officer

Mara Strandlund Chief People Officer (wtf woke-ism for HR)

Alex Szidon, PhD Chief Business Officer

Charlie Cooney, PhD Professor, MIT, Technical Advisory Board Chair

Beverly L. Davidson, PhD Chief Scientific Strategy Officer, The Children's Hospital of Philadelphia, Scientific Advisory Board Chair

Mark Mcclellan, MD, PhD Former FDA Commissioner, Regulatory Advisory Board Chair

==== Curious Domain History ==== ⁸⁾

1997 - Now you can get true 24-hour, 365-day availability and continuous processing from a SPARC-based system. Resilient® Resilient fault tolerant SPARC systems keep your critical Solaris applications - Internet/intranet, email, financial, database - running uninterrupted after any hardware failure. Complete systems start at $25,000. ⁹⁾

2016 - We build defense-in-depth solutions for customers with zero tolerance for security breaches, violations, or attacks. Wireless threats evolve quickly and often just beyond the edge of your network. Resilience RadioSleuth™ is the industry’s most advanced wireless intrusion prevention system, continuously scanning all wireless bands to detect and mitigate wireless threats before they get beyond your outer perimeter.¹⁰⁾

2020 - Resilience is changing the way medicine is made – leveraging innovation to better serve scientific discovery, withstand disruptive events, and reach those in need.

We’re bringing together brilliant minds in science and engineering with the most advanced technologies to build a resilient tomorrow, today.¹¹⁾

August 23, 2022 Company Linked to CIA Now Making mRNA for Moderna’s Reformulated COVID Booster Shots

Since late last year, messenger RNA for Moderna’s COVID-19 vaccines, including its recently reformulated Omicron booster, has been exclusively manufactured by National Resilience, a little-known company with significant ties to US intelligence. By Whitney Webb

The company initially marketed its manufacturing capabilities as “the Resilience platform,” and offers principally “RNA Modalities,” including RNA development for vaccines, gene editing and therapeutics; and “Virus Production,” including viral vectors, oncolytic viruses (i.e. a virus engineered to preferentially attack cancer cells), viruses for use in vaccine development and gene-edited viruses for unspecified purposes.

It is worth noting that, to date, many controversial “gain-of-function” experiments have justified modifying viruses for the same purposes as described by National Resilience’s Virus Production capabilities.

In addition, National Resilience offers product formulations and other modalities, such as biologics and cell therapies, to its clientele and the “Virus Production” of its website has since been removed. ¹²⁾

• White Rose Wiki